Navigation Links
Favrille Announces $21.1 Million Registered Direct Offering
Date:11/2/2007

SAN DIEGO, Nov. 2 /PRNewswire-FirstCall/ -- Favrille, Inc. (Nasdaq: FVRL) announced today that the Company has entered into definitive agreements with primarily institutional investors to sell up to 7,416,520 shares of its common stock and warrants to purchase up to 4,449,910 shares of its common stock for gross proceeds of approximately $21.1 million, before deducting placement agent fees and estimated offering expenses, in a "registered direct" offering. The investors have agreed to purchase the shares of common stock and warrants to purchase common stock (together, a "unit") at a negotiated purchase price of $2.845 per unit, each unit consisting of one share and a warrant to purchase 0.6 shares of common stock. The warrants will be exercisable at any time prior to the fifth anniversary of the closing of the transaction. The exercise price of the warrants will be $2.77 per share.

Lazard Capital Markets LLC served as sole placement agent for the offering.

The securities described above are being offered by the Company pursuant to a previously filed registration statement, which was declared effective by the Securities and Exchange Commission (the "SEC") on July 11, 2006. The transaction is expected to close on or about November 7, 2007, subject to customary closing conditions. The Company intends to use the net proceeds from this offering to fund its efforts to obtain FDA approval for its lead drug candidate FavId(R), to prepare for commercial launch of FavId and for other general corporate purposes.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state. Copies of the final prospectus supplement and accompanying base prospectus relating to this offering may be obtained at the SEC's website at '/>"/>

SOURCE Favrille, Inc.
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related biology technology :

1. Speaker announces business members of IT Task Force
2. Doyle announces technology tax credits for Berbee
3. Doyle announces new energy, global warming policies
4. Doyle announces $80M renewable energy strategy
5. GE announces first installation of Discovery VCT
6. UWM announces winners of RGI awards
7. Third Wave announces two senior management appointments
8. Mirus announces new method for making antibodies
9. Merge announces sofware updates, upcoming acquisition
10. Small Tree announces ethernet solution for Apple Xserv G5
11. TEKLYNX International announces new RFID software

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/5/2009)... Wound Management Technol...ntered into a Letter of Intent to purchase all hea...ies, Inc. (OTC Bulletin Board: VHGI). The deal pro...ebt, 4,000,000 shares of WNDM and a royalty agreem...p technology being acquired from VHGI. WNDM clos...
(Date:11/5/2009)...RNewswire-FirstCall/ -- WaferGen Biosystems, Inc. ... state-of-the-art genetic analysis systems, today ... the company,s Scientific Advisory Board. His car...ing novel molecular diagnostics for cancer detecti...of computational biology systems for several biote...
(Date:11/5/2009)... Nov. 5 /PRNewswire-Asia-FirstCall/ -- BMP Sunston...the "Company") today announced,that the Company pl...s on,Monday, November 9, 2009, after the market cl...e call at 5:00 pm ET on November 9, 2009,to discus...s the call by,dialing 1-888-713-4211 or 1-617-213-...
(Date:11/5/2009)...Surgery and vision correction experts listed in th...nvolved at the recently concluded American Academy... Francisco, California. Dr. Stephen Brint, MD, Dr.... MD, Dr. Peter Rapoza, MD, Dr. Michael Raizman, MD... Dr. Edward Manche, MD, and Dr. Parag Majmudar, MD...
Breaking Biology Technology:OTCBB-WNDM Announces LOI to Acquire VHGI Assets for $10 Million Cash/Stock 2OTCBB-WNDM Announces LOI to Acquire VHGI Assets for $10 Million Cash/Stock 3WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 2WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 3WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 4BMP Sunstone to Report Third Quarter 2009 Financial Results 2Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 2Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 3Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 4Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 5Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 6Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 7Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 8Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 9
...The Netherlands, March 10 Pepscan Therapeutics,(P...tone payment from Genmab,A/S. The milestone paymen...med at identifying human antibodies against intrac... CLIPS(TM) technology to generate immunogens that,...es against these,intractable targets. , Under ...
...March 10 Zimmer Holdings, Inc. (NYSE: ZMH ; SWX... the 29th Annual Cowen and Company Health Care Con...9, at 8:45 a.m. Eastern Time. , , A live webcast ...nvestor Relations website at http://investor.zimm...following the conference. , , About the Company ...
....J., March 10 The long-awaited speaking faculty f... & Exhibition has been posted on the conferenc...is LLC, the organizer. The chemistry faculty is c...nies and increasingly, biotech companies with smal...aker list may be viewed at www.chemoutsourcing.co...
Other Biology Technology:Pepscan Achieves First Milestone in Research Collaboration With Genmab 2Pharma ChemOutsourcing Unveils 100 Pharma & Biotech Speaker Faculty for 2009 Conference September 14-16 in Long Branch, NJ 2
(Date:11/4/2009)... DigitalPersona, Inc., a leader in..., today announced that WAND Corporation, a leading...k-service restaurants, has integrated DigitalPerso...OS solutions. WAND,s quick-service customers can n...ountability and deter unauthorized manager overrid...
(Date:11/4/2009)...ire/ -- What,s the cost of saving a teenage life? ...ting from prescription medication abuse, there,s n..., may be unaware that the lock-boxes they,ve insta...ng timebomb of prescription drugs. That,s why MEDN...al supplies, has formed an exclusive partnership w...
(Date:11/4/2009)...re-FirstCall/ -- BIO-key International, Inc. (OTC ...ometric identification software is showcasing dono...conference being held at the New Orleans Conventio...vide hands-on product demonstrations of its state-.... Also, at 5 PM on Monday, October 26, Peter Lux, ...
Breaking Biology News(10 mins):WAND Point-of-Sale Solutions Integrate U.are.U(R) Fingerprint Biometrics From DigitalPersona for Quick-Service Restaurants 2WAND Point-of-Sale Solutions Integrate U.are.U(R) Fingerprint Biometrics From DigitalPersona for Quick-Service Restaurants 3MEDNET Launches MedSafe to Prevent Teenage Prescription Drug Abuse 2MEDNET Launches MedSafe to Prevent Teenage Prescription Drug Abuse 3BIO-key(R) International Exhibiting at AABB TXPO 2New 3M CDI System Promotes Lasting Clinical Documentation Improvement 48861 1New 3M CDI System Promotes Lasting Clinical Documentation Improvement 48861 2New 3M CDI System Promotes Lasting Clinical Documentation Improvement 48861 3Transdel Pharmaceuticals Provides Update on Timing of Results for Phase 3 Study 48858 1Transdel Pharmaceuticals Provides Update on Timing of Results for Phase 3 Study 48858 2Transdel Pharmaceuticals Provides Update on Timing of Results for Phase 3 Study 48858 3Cancer Related Educational Video Sharing and Interactive Community Launches Online 48855 1Cancer Related Educational Video Sharing and Interactive Community Launches Online 48855 2Cancer Related Educational Video Sharing and Interactive Community Launches Online 48855 3
...ers at the Virginia Bioinformatics Institute (VBI)...Duke University Medical Center have developed a ne...de scale in the fungal pathogen Alternaria brassic...isease, leading to considerable leaf loss in such ...nd broccoli. , Genomic methods that allow the dis...
...ons, overexcitement is deadly. To avoid this, bra...om the synapse through membrane-bound transporters...rain cells get excited to death-- a phenomenon tha... Alzheimer,s disease. , Indeed, brain deterioratio...of glutamate -- the major excitatory neurotransmit...
...y is being published in an advance online version ...ked at XPB helicase from an archaea, a single cell...es that unwind or separate the strands of the nucl...to transcription and nucleotide excision repair (N... initially identified as the gene responsible for ...
Other Biology News:New method enables gene disruption in destructive fungal pathogen 2Enzyme crystal structure reveals 'unexpected' genome repair functions 2
... SYBR Green, TaqMan, LNA spiked TaqMan, MethyLight...specific primers are designed by avoiding cross ho... search results. Primer efficiency is enhanced by ...by connecting to the Mfold server. Beacon Designer...
Goat Anti-Human IL-17D Polyclonal Antibody, Unconjugated from R&D Systems
...-ADP, FHS-LVF and CVD-Diffuse We've combined our ...lters to create the world's first notch filter wit...andpass. Each filter features an excellent transmi...e filters -- with interference coatings applied to...
Agar - ULTRAPURE from GE Healthcare, formerly Amersham Biosciences
Biology Products: